Incidence and prognosis of carcinoid syndrome: hormones or tumour burden?
Lancet Oncol
.
2017 Jun;18(6):e299.
doi: 10.1016/S1470-2045(17)30335-2.
Authors
Wouter T Zandee
1
,
Wouter W de Herder
2
,
Henning Jann
3
Affiliations
1
Erasmus Medical Center, Rotterdam 3015 CE, Netherlands. Electronic address:
[email protected]
.
2
Erasmus Medical Center, Rotterdam 3015 CE, Netherlands.
3
Charité, Campus Virchow Klinikum, University Medicine Berlin, Germany.
PMID:
28593854
DOI:
10.1016/S1470-2045(17)30335-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoid Tumor
Humans
Incidence
Malignant Carcinoid Syndrome*
Prognosis
Tumor Burden*